Oncimmune Holdings plc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.1
John Goold Non-Executive Director Executive Director
Transaction date
Purchase
Price
202.53
Quantity 17,922
Value £2,365,987
2.3
Martin Gouldstone Chief Executive Officer Officer
Transaction date
Purchase
Price
131.53
Quantity 30,106
Value £631,063
2.2
Alistair Macdonald Chairman Director
Transaction date
Purchase
Price
42.34
Quantity 78,860
Value £3,225,959
Mr Martin Gouldstone Chief Executive Officer Officer
Transaction date
Purchase
Price
0.27
Quantity 36,023
Value £9,816
Dr Adam Mark Hill Chief Executive Officer Officer
Transaction date
Purchase
Price
0.21
Quantity 48,370
Value £9,990
Tim Bunting Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.45
Quantity 1,900,000
Value £855,000
2.2
Alistair Macdonald Non-Executive Chairman Director
Transaction date
Purchase
Price
0.45
Quantity 55,555
Value £25,000
Dr Adam Mark Hill Chief Executive Officer Officer
Transaction date
Purchase
Price
0.62
Quantity 8,005
Value £5,000
3.0
Matthew Hall Chief Financial Officer Officer
Transaction date
Sale
Price
1.35
Quantity 10,000
Value £13,500
3.0
Matthew Hall Chief Financial Officer Officer
Transaction date
Sale
Price
1.40
Quantity 20,000
Value £28,000
Dr Adam Mark Hill Chief Executive Officer Officer
Transaction date
Purchase
Price
1.33
Quantity 7,533
Value £10,000
Dr Adam Mark Hill Chief Executive Officer Officer
Transaction date
Purchase
Price
1.68
Quantity 5,669
Value £9,498
Dr Adam Mark Hill Chief Executive Officer Officer
Transaction date
Purchase
Price
1.67
Quantity 5,988
Value £10,000
Dr Cheung To Non-Executive Director Executive Director
Through Genostics Company Limited, a closely affiliated person
Transaction date
Sale
Price
1.85
Quantity 40,000
Value £74,000
Dr Cheung To Non-Executive Director Executive Director
Through Genostics Company Limited, a closely affiliated person
Transaction date
Sale
Price
1.85
Quantity 10,000
Value £18,500
Dr Cheung To Non-Executive Director Executive Director
Through Genostics Company Limited, a closely affiliated person
Transaction date
Sale
Price
1.75
Quantity 50,000
Value £87,500
Dr Cheung To Non-Executive Director Executive Director
Through Genostics Company Limited, a closely affiliated person
Transaction date
Sale
Price
0.00
Quantity 50,000
Value £2
Dr Cheung To Non-Executive Director Executive Director
Through Genostics Company Limited, a closely affiliated person
Transaction date
Sale
Price
1.70
Quantity 5,000
Value £8,500
Dr Adam Mark Hill Chief Executive Officer Officer
Transaction date
Purchase
Price
1.73
Quantity 5,764
Value £9,999
Dr Cheung To Non-Executive Director Executive Director
Through Genostics Company Limited, a closely affiliated person
Transaction date
Sale
Price
0.00
Quantity 30,000
Value £2
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-11 2024-10-23 B Purchase

Non-Executive Director

Executive Director
17,922
202.53
£2,365,987
17,922 202.53 £2,365,987
2024-11-11 2024-10-23 B Purchase

Chief Executive Officer

Officer
30,106
131.53
£631,063
30,106 131.53 £631,063
2024-11-11 2024-10-23 B Purchase

Chairman

Director
78,860
42.34
£3,225,959
78,860 42.34 £3,225,959
2023-12-11 2023-12-08 B Purchase Mr Martin Gouldstone

Chief Executive Officer

Officer
36,023
0.27
£9,816
36,023 0.27 £9,816
2023-06-05 2023-06-05 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
48,370
0.21
£9,990
48,370 0.21 £9,990
2022-12-19 2022-12-16 B Purchase Tim Bunting

Non-Executive Director

Executive Director
1,900,000
0.45
£855,000
1,900,000 0.45 £855,000
2022-12-19 2022-12-16 B Purchase

Non-Executive Chairman

Director
55,555
0.45
£25,000
55,555 0.45 £25,000
2022-09-21 2022-09-21 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
8,005
0.62
£5,000
8,005 0.62 £5,000
2022-03-29 2022-03-25 S Sale

Chief Financial Officer

Officer
10,000
1.35
£13,500
10,000 1.35 £13,500
2022-03-29 2022-03-24 S Sale

Chief Financial Officer

Officer
20,000
1.40
£28,000
20,000 1.40 £28,000
2022-03-07 2022-03-07 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
7,533
1.33
£10,000
7,533 1.33 £10,000
2021-12-24 2021-12-23 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
5,669
1.68
£9,498
5,669 1.68 £9,498
2021-12-21 2021-12-21 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
5,988
1.67
£10,000
5,988 1.67 £10,000
2021-01-14 2021-01-11 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
40,000
1.85
£74,000
40,000 1.85 £74,000
2021-01-14 2021-01-08 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
10,000
1.85
£18,500
10,000 1.85 £18,500
2021-01-14 2021-01-05 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
50,000
1.75
£87,500
50,000 1.75 £87,500
2021-01-14 2021-01-05 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
50,000
0.00
£2
50,000 0.00 £2
2021-01-14 2020-12-21 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
5,000
1.70
£8,500
5,000 1.70 £8,500
2020-12-18 2020-12-17 B Purchase Dr Adam Mark Hill

Chief Executive Officer

Officer
5,764
1.73
£9,999
5,764 1.73 £9,999
2021-01-14 2020-12-14 S Sale Dr Cheung To

Non-Executive Director

Through Genostics Company Limited, a closely affiliated person Executive Director
30,000
0.00
£2
30,000 0.00 £2
Explore more

More insider trading research around Oncimmune Holdings plc